Top Biotechnology companies in Australia by Cash and Short-Term Investments

This ranking features the top 16 Biotechnology companies in Australia ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 3.10 B, for February 06, 2025.
#
Name
Cash and Short-Term Investments
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 1.66 B
June 30, 2024 USD 169.95 -0.56%

Australia

2
USD 430.06 M
June 30, 2024 USD 17.72 0.58%

Australia

3
USD 342.45 M
June 30, 2024 USD 195.76 0.28%

Australia

4
USD 122.60 M
June 30, 2024 USD 7.27 0.71%

Australia

5
USD 121.27 M
June 30, 2024 USD 2.09 0.97%

Australia

6
USD 99.53 M
June 30, 2024 USD 2.89 2.85%

Australia

7
USD 83.93 M
Dec. 31, 2023 USD 18.33 -0.84%

Australia

8
USD 62.56 M
June 30, 2024 USD 1.90 -4.74%

Australia

9
USD 40.07 M
June 30, 2024 USD 0.87 -0.82%

Australia

10
USD 30.64 M
June 30, 2024 USD 1.23 -0.40%

Australia

11
USD 30.08 M
June 30, 2024 USD 0.74 1.48%

Australia

12
USD 28.30 M
June 30, 2024 USD 1.90 0.29%

Australia

13
USD 21.00 M
Dec. 31, 2023 USD 6.16 2.82%

Australia

14
USD 17.90 M
June 30, 2024 USD 2.33 0.08%

Australia

15
USD 7.99 M
Dec. 31, 2023 USD 1.45 -3.95%

Australia

16
USD 7.56 M
June 30, 2024 USD 0.74 0.62%

Australia

Frequently Asked Questions
  • Which Biotechnology company in Australia has the highest Cash and Short-Term Investments ?

    The Biotechnology company in Australia with the highest Cash and Short-Term Investments is CSL Limited (ASX: CSL.AX) at USD 1.66 B.

  • Which Biotechnology company in Australia has the lowest Cash and Short-Term Investments ?

    The Biotechnology company in Australia with the lowest Cash and Short-Term Investments is Monash IVF Group Limited (ASX: MVF.AX) at USD 7.56 M.

SV Wall Street